196 related articles for article (PubMed ID: 15988378)
1. Genetic testing for pheochromocytoma-associated syndromes.
Pawlu C; Bausch B; Reisch N; Neumann HP
Ann Endocrinol (Paris); 2005 Jun; 66(3):178-85. PubMed ID: 15988378
[TBL] [Abstract][Full Text] [Related]
2. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
[TBL] [Abstract][Full Text] [Related]
3. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
Nesković G; Stanojević B; Palmar I; Dimitrijević B
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
[TBL] [Abstract][Full Text] [Related]
4. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
Opocher G; Conton P; Schiavi F; Macino B; Mantero F
Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
[TBL] [Abstract][Full Text] [Related]
5. Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx.
Gimm O
Fam Cancer; 2005; 4(1):17-23. PubMed ID: 15883706
[TBL] [Abstract][Full Text] [Related]
6. Germ-line mutations in nonsyndromic pheochromocytoma.
Neumann HP; Bausch B; McWhinney SR; Bender BU; Gimm O; Franke G; Schipper J; Klisch J; Altehoefer C; Zerres K; Januszewicz A; Eng C; Smith WM; Munk R; Manz T; Glaesker S; Apel TW; Treier M; Reineke M; Walz MK; Hoang-Vu C; Brauckhoff M; Klein-Franke A; Klose P; Schmidt H; Maier-Woelfle M; Peçzkowska M; Szmigielski C; Eng C;
N Engl J Med; 2002 May; 346(19):1459-66. PubMed ID: 12000816
[TBL] [Abstract][Full Text] [Related]
7. New insights into the genetics of familial chromaffin cell tumors.
Koch CA; Vortmeyer AO; Zhuang Z; Brouwers FM; Pacak K
Ann N Y Acad Sci; 2002 Sep; 970():11-28. PubMed ID: 12381538
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.
Dannenberg H; Komminoth P; Dinjens WN; Speel EJ; de Krijger RR
Endocr Pathol; 2003; 14(4):329-50. PubMed ID: 14739490
[TBL] [Abstract][Full Text] [Related]
9. Genetic aspects of pheochromocytoma.
Koch CA; Vortmeyer AO; Huang SC; Alesci S; Zhuang Z; Pacak K
Endocr Regul; 2001 Mar; 35(1):43-52. PubMed ID: 11308996
[TBL] [Abstract][Full Text] [Related]
10. Familial pheochromocytoma.
Erlic Z; Neumann HP
Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
[TBL] [Abstract][Full Text] [Related]
11. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene.
Brauch H; Hoeppner W; Jähnig H; Wöhl T; Engelhardt D; Spelsberg F; Ritter MM
J Clin Endocrinol Metab; 1997 Dec; 82(12):4101-4. PubMed ID: 9398721
[TBL] [Abstract][Full Text] [Related]
12. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
13. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
[TBL] [Abstract][Full Text] [Related]
14. Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.
Erlic Z; Hoffmann MM; Sullivan M; Franke G; Peczkowska M; Harsch I; Schott M; Gabbert HE; Valimäki M; Preuss SF; Hasse-Lazar K; Waligorski D; Robledo M; Januszewicz A; Eng C; Neumann HP
J Clin Endocrinol Metab; 2010 Jan; 95(1):308-13. PubMed ID: 19906784
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
Crossey PA; Eng C; Ginalska-Malinowska M; Lennard TW; Wheeler DC; Ponder BA; Maher ER
J Med Genet; 1995 Nov; 32(11):885-6. PubMed ID: 8592333
[TBL] [Abstract][Full Text] [Related]
16. The pressure rises: update on the genetics of phaeochromocytoma.
Maher ER; Eng C
Hum Mol Genet; 2002 Oct; 11(20):2347-54. PubMed ID: 12351569
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytoma: the expanding genetic differential diagnosis.
Bryant J; Farmer J; Kessler LJ; Townsend RR; Nathanson KL
J Natl Cancer Inst; 2003 Aug; 95(16):1196-204. PubMed ID: 12928344
[TBL] [Abstract][Full Text] [Related]
18. Bilateral pheochromocytomas and congenital anomalies associated with a de novo germline mutation in the von Hippel-Lindau gene.
Assadi F; Brackbill EL
Am J Kidney Dis; 2003 Jan; 41(1):E3. PubMed ID: 12500216
[TBL] [Abstract][Full Text] [Related]
19. Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.
Koch CA; Huang SC; Zhuang Z; Stolle C; Azumi N; Chrousos GP; Vortmeyer AO; Pacak K
Oncogene; 2002 Jan; 21(3):479-82. PubMed ID: 11821960
[TBL] [Abstract][Full Text] [Related]
20. Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas.
Krawczyk A; Hasse-Lazar K; Pawlaczek A; Szpak-Ulczok S; Krajewska J; Paliczka-Cieślak E; Jurecka-Lubieniecka B; Roskosz J; Chmielik E; Ziaja J; Cierpka L; Peczkowska M; Preibisz A; Januszewicz A; Otto M; Jarzab B
Endokrynol Pol; 2010; 61(1):43-8. PubMed ID: 20205103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
